NeuroScios

NeuroScios is a specialized Contract Research Organization (CRO) that provides end-to-end drug development services focused exclusively on neuroscience and central nervous system (CNS) disorders. Headquartered in Graz, Austria, the company supports pharmaceutical and biotechnology firms through all stages of development, from preclinical research and animal models to Phase I-IV clinical trials. NeuroScios is particularly recognized for its expertise in neurodegenerative diseases such as Alzheimer's and Parkinson's, offering specialized services in biomarker analysis, neuroimaging, and clinical site management. The company provides a bridge between preclinical discovery and clinical proof-of-concept, utilizing a network of specialized clinical centers across Europe and North America. Their service portfolio includes regulatory consulting, project management, and data management tailored to the unique challenges of neurological research. By combining deep scientific knowledge with operational excellence, NeuroScios helps accelerate the development of novel therapies for complex neurological conditions.